Healthcare entity
All 3 tracked stories fall under one category: regulation. Of the tracked stories, 2 of 3 also mention MMJ International Holdings, Inc., the most common co-covered peer. At 7, the average consequence score sits above the same-window beat average of 5.9.
Last mentioned: Aug 16, 2026
Entity pulse
Coverage balance Balanced directional read. Positive and negative coverage are within 0 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 3 tracked stories fall under one category: regulation. Of the tracked stories, 2 of 3 also mention MMJ International Holdings, Inc., the most common co-covered peer. At 7, the average consequence score sits above the same-window beat average of 5.9. Source depth averages 1.7 original sources per story, versus 3.3 across the same-window beat baseline. That works out to roughly 0.6 stories per week across a 36-day span. We currently track 3 Healthcare stories that mention Duane Boise, published between July 12, 2026 and August 16, 2026.
Computed from the 3 stories linked to this entity, with beat comparisons drawn from all 352 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Duane Boise. Shared-story counts are live from our verified record — not editorial picks.
Scheduled DEA hearing on rescheduling
A DEA administrative hearing is set to take place, which CEO Duane Boise calls less significant than the appellate court action.
MMJ announces advancement of legal challenge
Company issues press release declaring that the D.C. Circuit challenge has advanced and that the operative legal event is the court review, not the upcoming DEA hearing.
Statement of Issues filed
MMJIH files a Statement of Issues in the D.C. Circuit Court of Appeals seeking vacatur of the Final Order.
Acting Attorney General issues Final Order
Todd Blanche places marijuana into Schedule III of the Controlled Substances Act via a Final Order.
Initial DEA hearing process begins
A hearing process on marijuana rescheduling begins under the Controlled Substances Act, later terminated by the government according to petitioners.
Health systems and health IT vendors building around CMS's hemp-derived cannabinoid initiative are on contested regulatory ground. A successful federal challenge could stay or remand the program, changing compliance and reimbursement calculations.
MMJ International Holdings' appeal to the D.C. Circuit exposes a procedural flaw in the DEA's marijuana rescheduling that could delay patient access to new cannabinoid medicines and create confusion for healthcare providers trying to navigate the shifting regulatory landscape.
Source: tennesseedaily.com · pr-inside.com
MMJ International Holdings says moving cannabis to Schedule III would wipe out $2.24B in annual excess 280E taxes, unlocking capital for patient programs and medical research. The legal dispute spotlights the massive healthcare economic stakes of drug scheduling.
Source: finanznachrichten.de
Duane Boise is linked from 3 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
